# Erector Spinae Versus Intercostal Nerve Blocks With Liposomal Bupivacaine for Analgesia in Thoracic Surgery

Source: https://onco.cc/trials/nct06810375/  
OnCo record `nct06810375` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 3 trial in lung cancer, run by George Washington University, now recruiting.

## Summary

Erector Spinae Versus Intercostal Nerve Blocks With Liposomal Bupivacaine for Analgesia in Thoracic Surgery is a phase 3, randomised interventional study registered as NCT06810375 by George Washington University, with a registry enrolment figure of 120 participants, started 2025-03-01 and due to reach its primary completion in 2028-02-28. Interventions recorded: Erector Spinae (ESP) Block with Bupivacaine (Marcaine®); Intercostal nerve block. Conditions listed: Lung Cancers. Primary outcome: Postoperative pain control assessment; Morphine equivalent assessment. Sites: United States. No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-25
- Tags: ctgov-ingest; lung-deep-dive
- Registry id: NCT06810375
- Phase: 3
- Setting: Erector Spinae Versus Intercostal Nerve Blocks With Liposomal Bupivacaine for Analgesia in Thoracic Surgery
- Sponsor: George Washington University
- Enrolled: 120

## Sources

- ClinicalTrials.gov NCT06810375: https://clinicaltrials.gov/study/NCT06810375

## Connected records

- cancers: [Lung cancer (all types)](https://onco.cc/cancers/lung-cancer/)
- terms: [Lung cancer trials open today (registry snapshot)](https://onco.cc/terms/lung-trials-open-today/)

---
JSON: https://onco.cc/api/v1/entities/nct06810375.json